Anticancer acumens of three Annona species: a proportional review
Introduction Cumulative pattern of cancer could be seen in day-to-day life with each passing year and, it is becoming a great matter of concern especially to the scientific community worldwide. Alternative treatment methods for various types of cancer are in place and, being continuously worked out....
Gespeichert in:
Veröffentlicht in: | Journal of cancer research and clinical oncology 2023-08, Vol.149 (9), p.6693-6702 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6702 |
---|---|
container_issue | 9 |
container_start_page | 6693 |
container_title | Journal of cancer research and clinical oncology |
container_volume | 149 |
creator | Balkrishna, Acharya Dabhade, Neelam R. Singh, Ashwini Arya, Vedpriya |
description | Introduction
Cumulative pattern of cancer could be seen in day-to-day life with each passing year and, it is becoming a great matter of concern especially to the scientific community worldwide. Alternative treatment methods for various types of cancer are in place and, being continuously worked out. Plant-derived natural substances have shown great results in combating cancer in comparison to chemo and radiotherapies which are toxic besides having serious side effects. In continuation,
Annona
species, native to America, Africa, Asia and Australia have been used in folk medicines and, are reported to have many anti-carcinogenic substances.
Methods
For a prudent understanding of
Annona
species against various cancers, comparative investigation and analysis of three species viz
., A. cherimola
,
A. muricata
, and
A. squamosa
was undertaken through a detailed review of the in-attendance subject. The major scientific biomedical literature databases were consulted and the information available from 2011 until January 2021 was taken into account.
Results
Studies on anti-cancer activities along with the thorough analysis of the findings and the pieces of evidence supporting their anti-proliferative, apoptosis, G
1
cell cycle arrest and cytotoxic effects are described.
A. muricata
displayed maximum number of anti-cancer activities being revealed by most of its parts with the lowest IC
50
values against various cancer cell lines compared to
A. cherimola
and
A. squamosa
. On account of the findings, it is advocated that, further detailed studies on anti-cancer explorations of
Annona
species could be proved fruitful in paving new and innovative methodologies for novel anti-cancer drug discovery and development. |
doi_str_mv | 10.1007/s00432-022-04306-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2839649339</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2839649339</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-f95b90c8c127926bf5569be580f241513d09ee595122148aba2da476b05d12e73</originalsourceid><addsrcrecordid>eNp9kE1PwzAMhiMEYmPwBzigSJwL-U7DrZr4kpC4wDlKUxc6bW1JWhD_nowOuHGwLNuvX1sPQqeUXFBC9GUkRHCWEZZCcKIyuYfmdNuinMt9NCdU00wyqmboKMYVSbXU7BDNuFKa0FzMUVG0Q-Nd6yFg58cNtBF3NR5eAwAu2rZrHY49-AbiFXa4D13fhaFJ7TUO8N7AxzE6qN06wskuL9DzzfXT8i57eLy9XxYPmedaDlltZGmIzz1l2jBV1lIqU4LMSc0ElZRXxABIIyljVOSudKxyQquSyIoy0HyBziff9MPbCHGwq24M6Y9oWc6NEoZzk1RsUvnQxRigtn1oNi58WkrslpqdqNlEzX5TszItne2sx3ID1e_KD6Yk4JMgplH7AuHv9j-2X9L4dew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2839649339</pqid></control><display><type>article</type><title>Anticancer acumens of three Annona species: a proportional review</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Balkrishna, Acharya ; Dabhade, Neelam R. ; Singh, Ashwini ; Arya, Vedpriya</creator><creatorcontrib>Balkrishna, Acharya ; Dabhade, Neelam R. ; Singh, Ashwini ; Arya, Vedpriya</creatorcontrib><description>Introduction
Cumulative pattern of cancer could be seen in day-to-day life with each passing year and, it is becoming a great matter of concern especially to the scientific community worldwide. Alternative treatment methods for various types of cancer are in place and, being continuously worked out. Plant-derived natural substances have shown great results in combating cancer in comparison to chemo and radiotherapies which are toxic besides having serious side effects. In continuation,
Annona
species, native to America, Africa, Asia and Australia have been used in folk medicines and, are reported to have many anti-carcinogenic substances.
Methods
For a prudent understanding of
Annona
species against various cancers, comparative investigation and analysis of three species viz
., A. cherimola
,
A. muricata
, and
A. squamosa
was undertaken through a detailed review of the in-attendance subject. The major scientific biomedical literature databases were consulted and the information available from 2011 until January 2021 was taken into account.
Results
Studies on anti-cancer activities along with the thorough analysis of the findings and the pieces of evidence supporting their anti-proliferative, apoptosis, G
1
cell cycle arrest and cytotoxic effects are described.
A. muricata
displayed maximum number of anti-cancer activities being revealed by most of its parts with the lowest IC
50
values against various cancer cell lines compared to
A. cherimola
and
A. squamosa
. On account of the findings, it is advocated that, further detailed studies on anti-cancer explorations of
Annona
species could be proved fruitful in paving new and innovative methodologies for novel anti-cancer drug discovery and development.</description><identifier>ISSN: 0171-5216</identifier><identifier>EISSN: 1432-1335</identifier><identifier>DOI: 10.1007/s00432-022-04306-5</identifier><identifier>PMID: 36670184</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Annona ; Annona - metabolism ; Antineoplastic Agents - pharmacology ; Antineoplastic Agents - therapeutic use ; Antitumor agents ; Apoptosis ; Cancer ; Cancer Research ; Cell cycle ; Cell Proliferation ; Cytotoxicity ; Hematology ; Humans ; Indigenous species ; Internal Medicine ; Introduced species ; Medicine ; Medicine & Public Health ; Oncology ; Plant Extracts - pharmacology ; Plant Extracts - therapeutic use ; Plants ; Radiation therapy ; Review ; Tumor cell lines</subject><ispartof>Journal of cancer research and clinical oncology, 2023-08, Vol.149 (9), p.6693-6702</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-f95b90c8c127926bf5569be580f241513d09ee595122148aba2da476b05d12e73</citedby><cites>FETCH-LOGICAL-c375t-f95b90c8c127926bf5569be580f241513d09ee595122148aba2da476b05d12e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00432-022-04306-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00432-022-04306-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36670184$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Balkrishna, Acharya</creatorcontrib><creatorcontrib>Dabhade, Neelam R.</creatorcontrib><creatorcontrib>Singh, Ashwini</creatorcontrib><creatorcontrib>Arya, Vedpriya</creatorcontrib><title>Anticancer acumens of three Annona species: a proportional review</title><title>Journal of cancer research and clinical oncology</title><addtitle>J Cancer Res Clin Oncol</addtitle><addtitle>J Cancer Res Clin Oncol</addtitle><description>Introduction
Cumulative pattern of cancer could be seen in day-to-day life with each passing year and, it is becoming a great matter of concern especially to the scientific community worldwide. Alternative treatment methods for various types of cancer are in place and, being continuously worked out. Plant-derived natural substances have shown great results in combating cancer in comparison to chemo and radiotherapies which are toxic besides having serious side effects. In continuation,
Annona
species, native to America, Africa, Asia and Australia have been used in folk medicines and, are reported to have many anti-carcinogenic substances.
Methods
For a prudent understanding of
Annona
species against various cancers, comparative investigation and analysis of three species viz
., A. cherimola
,
A. muricata
, and
A. squamosa
was undertaken through a detailed review of the in-attendance subject. The major scientific biomedical literature databases were consulted and the information available from 2011 until January 2021 was taken into account.
Results
Studies on anti-cancer activities along with the thorough analysis of the findings and the pieces of evidence supporting their anti-proliferative, apoptosis, G
1
cell cycle arrest and cytotoxic effects are described.
A. muricata
displayed maximum number of anti-cancer activities being revealed by most of its parts with the lowest IC
50
values against various cancer cell lines compared to
A. cherimola
and
A. squamosa
. On account of the findings, it is advocated that, further detailed studies on anti-cancer explorations of
Annona
species could be proved fruitful in paving new and innovative methodologies for novel anti-cancer drug discovery and development.</description><subject>Annona</subject><subject>Annona - metabolism</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Antitumor agents</subject><subject>Apoptosis</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Cell cycle</subject><subject>Cell Proliferation</subject><subject>Cytotoxicity</subject><subject>Hematology</subject><subject>Humans</subject><subject>Indigenous species</subject><subject>Internal Medicine</subject><subject>Introduced species</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Plant Extracts - pharmacology</subject><subject>Plant Extracts - therapeutic use</subject><subject>Plants</subject><subject>Radiation therapy</subject><subject>Review</subject><subject>Tumor cell lines</subject><issn>0171-5216</issn><issn>1432-1335</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kE1PwzAMhiMEYmPwBzigSJwL-U7DrZr4kpC4wDlKUxc6bW1JWhD_nowOuHGwLNuvX1sPQqeUXFBC9GUkRHCWEZZCcKIyuYfmdNuinMt9NCdU00wyqmboKMYVSbXU7BDNuFKa0FzMUVG0Q-Nd6yFg58cNtBF3NR5eAwAu2rZrHY49-AbiFXa4D13fhaFJ7TUO8N7AxzE6qN06wskuL9DzzfXT8i57eLy9XxYPmedaDlltZGmIzz1l2jBV1lIqU4LMSc0ElZRXxABIIyljVOSudKxyQquSyIoy0HyBziff9MPbCHGwq24M6Y9oWc6NEoZzk1RsUvnQxRigtn1oNi58WkrslpqdqNlEzX5TszItne2sx3ID1e_KD6Yk4JMgplH7AuHv9j-2X9L4dew</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Balkrishna, Acharya</creator><creator>Dabhade, Neelam R.</creator><creator>Singh, Ashwini</creator><creator>Arya, Vedpriya</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20230801</creationdate><title>Anticancer acumens of three Annona species: a proportional review</title><author>Balkrishna, Acharya ; Dabhade, Neelam R. ; Singh, Ashwini ; Arya, Vedpriya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-f95b90c8c127926bf5569be580f241513d09ee595122148aba2da476b05d12e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Annona</topic><topic>Annona - metabolism</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Antitumor agents</topic><topic>Apoptosis</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Cell cycle</topic><topic>Cell Proliferation</topic><topic>Cytotoxicity</topic><topic>Hematology</topic><topic>Humans</topic><topic>Indigenous species</topic><topic>Internal Medicine</topic><topic>Introduced species</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Plant Extracts - pharmacology</topic><topic>Plant Extracts - therapeutic use</topic><topic>Plants</topic><topic>Radiation therapy</topic><topic>Review</topic><topic>Tumor cell lines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balkrishna, Acharya</creatorcontrib><creatorcontrib>Dabhade, Neelam R.</creatorcontrib><creatorcontrib>Singh, Ashwini</creatorcontrib><creatorcontrib>Arya, Vedpriya</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of cancer research and clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Balkrishna, Acharya</au><au>Dabhade, Neelam R.</au><au>Singh, Ashwini</au><au>Arya, Vedpriya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anticancer acumens of three Annona species: a proportional review</atitle><jtitle>Journal of cancer research and clinical oncology</jtitle><stitle>J Cancer Res Clin Oncol</stitle><addtitle>J Cancer Res Clin Oncol</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>149</volume><issue>9</issue><spage>6693</spage><epage>6702</epage><pages>6693-6702</pages><issn>0171-5216</issn><eissn>1432-1335</eissn><abstract>Introduction
Cumulative pattern of cancer could be seen in day-to-day life with each passing year and, it is becoming a great matter of concern especially to the scientific community worldwide. Alternative treatment methods for various types of cancer are in place and, being continuously worked out. Plant-derived natural substances have shown great results in combating cancer in comparison to chemo and radiotherapies which are toxic besides having serious side effects. In continuation,
Annona
species, native to America, Africa, Asia and Australia have been used in folk medicines and, are reported to have many anti-carcinogenic substances.
Methods
For a prudent understanding of
Annona
species against various cancers, comparative investigation and analysis of three species viz
., A. cherimola
,
A. muricata
, and
A. squamosa
was undertaken through a detailed review of the in-attendance subject. The major scientific biomedical literature databases were consulted and the information available from 2011 until January 2021 was taken into account.
Results
Studies on anti-cancer activities along with the thorough analysis of the findings and the pieces of evidence supporting their anti-proliferative, apoptosis, G
1
cell cycle arrest and cytotoxic effects are described.
A. muricata
displayed maximum number of anti-cancer activities being revealed by most of its parts with the lowest IC
50
values against various cancer cell lines compared to
A. cherimola
and
A. squamosa
. On account of the findings, it is advocated that, further detailed studies on anti-cancer explorations of
Annona
species could be proved fruitful in paving new and innovative methodologies for novel anti-cancer drug discovery and development.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>36670184</pmid><doi>10.1007/s00432-022-04306-5</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0171-5216 |
ispartof | Journal of cancer research and clinical oncology, 2023-08, Vol.149 (9), p.6693-6702 |
issn | 0171-5216 1432-1335 |
language | eng |
recordid | cdi_proquest_journals_2839649339 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Annona Annona - metabolism Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Antitumor agents Apoptosis Cancer Cancer Research Cell cycle Cell Proliferation Cytotoxicity Hematology Humans Indigenous species Internal Medicine Introduced species Medicine Medicine & Public Health Oncology Plant Extracts - pharmacology Plant Extracts - therapeutic use Plants Radiation therapy Review Tumor cell lines |
title | Anticancer acumens of three Annona species: a proportional review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T04%3A35%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anticancer%20acumens%20of%20three%20Annona%20species:%20a%20proportional%20review&rft.jtitle=Journal%20of%20cancer%20research%20and%20clinical%20oncology&rft.au=Balkrishna,%20Acharya&rft.date=2023-08-01&rft.volume=149&rft.issue=9&rft.spage=6693&rft.epage=6702&rft.pages=6693-6702&rft.issn=0171-5216&rft.eissn=1432-1335&rft_id=info:doi/10.1007/s00432-022-04306-5&rft_dat=%3Cproquest_cross%3E2839649339%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2839649339&rft_id=info:pmid/36670184&rfr_iscdi=true |